Analysis of Morbidity and Mortality of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients Age ≥ 65 Years

被引：0
|
作者：
Turner, Keli
Kesmodel, Susan B.
Boutros, Cherif
Alexander, H. Richard
Hanna, Nader
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo2050
引用
收藏
页码：S1076 / S1076
页数：1
相关论文
共 50 条
  • [21] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality
    Cripe, James
    Tseng, Jill
    Eskander, Ramez
    Fader, Amanda Nickles
    Tanner, Edward
    Bristow, Robert
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (02) : 655 - 661
  • [22] Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer
    Cascales Campos, P.
    Gil, Jose
    Parrilla, Pascual
    EJSO, 2014, 40 (08): : 970 - 975
  • [23] Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique
    Stephens, AD
    Alderman, R
    Chang, D
    Edwards, GD
    Esquivel, J
    Sebbag, G
    Steves, MA
    Sugarbaker, PH
    ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (08) : 790 - 796
  • [24] Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique
    Arvil D. Stephens
    Robert Alderman
    David Chang
    Gary D. Edwards
    Jesus Esquivel
    Gilbert Sebbag
    Mark A. Steves
    Paul H. Sugarbaker
    Annals of Surgical Oncology, 1999, 6 : 790 - 796
  • [25] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality
    James Cripe
    Jill Tseng
    Ramez Eskander
    Amanda Nickles Fader
    Edward Tanner
    Robert Bristow
    Annals of Surgical Oncology, 2015, 22 : 655 - 661
  • [26] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Durnford, S.
    Boss, L.
    Bell, J.
    BJA EDUCATION, 2021, 21 (05) : 187 - 193
  • [27] Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
    Eng, Oliver S.
    Dumitra, Sinziana
    O'Leary, Michael
    Raoof, Mustafa
    Wakabayashi, Mark
    Dellinger, Thanh H.
    Han, Ernest S.
    Lee, Stephen J.
    Paz, I. Benjamin
    Lee, Byrne
    JAMA SURGERY, 2017, 152 (12) : 1156 - 1160
  • [28] Abdominal Wall Morbidity Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Struller, F.
    Koenigsrainer, I.
    Horvath, P.
    Koenigsrainer, A.
    Beckert, S.
    SCANDINAVIAN JOURNAL OF SURGERY, 2017, 106 (04) : 294 - 298
  • [29] Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality
    Votanopoulos, Konstantinos I.
    Newman, Naeem A.
    Russell, Greg
    Ihemelandu, Chukwuemeka
    Shen, Perry
    Stewart, John H.
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (11) : 3497 - 3503
  • [30] Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality
    Konstantinos I. Votanopoulos
    Naeem A. Newman
    Greg Russell
    Chukwuemeka Ihemelandu
    Perry Shen
    John H. Stewart
    Edward A. Levine
    Annals of Surgical Oncology, 2013, 20 : 3497 - 3503
12345